Purchases and Sales Made in Q2 2023 in Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE) during Q2 2023. The information is specifically focused on institutions that hold shares of FATE THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-538K- 35.86% |
$2.56M - $3.54M
|
962K
$1.26M
|
|
|
Aug 14, 2023
Q2 2023
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-625K- 42.83% |
$2.97M - $4.12M
|
834K
$1.09M
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-661K- 49.56% |
$3.14M - $4.35M
|
672K
$881K
|
|
|
Aug 14, 2023
Q2 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-705KClosed |
$3.36M - $4.65M
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-933K- 43.29% |
$4.44M - $6.15M
|
1.22M
$1.6M
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.11M- 63.93% |
$5.27M - $7.3M
|
625K
$819K
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-4.52M- 30.45% |
$21.5M - $29.8M
|
10.3M
$13.5M
|